This well-characterized DN model provides a robust experimental platform for evaluating antidiabetic nephropathy candidates, supporting your drug development program with validated, reproducible data.
This promotional material will provide you with a detailed presentation of:
Download the case study to access complete experimental parameters, raw data outputs, and histopathological images. Then contact us to discuss how this model can be tailored to your DN drug evaluation program.
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.